Orchestra BioMed Holdings, Inc. - OBIO

About Gravity Analytica
Recent News
- 09.04.2025 - Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
- 09.04.2025 - Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
- 08.26.2025 - Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
- 08.26.2025 - Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
- 08.25.2025 - Blog Post - OBIO | Strategic Recaps: The Power of Partnership and Future of AVIM Therapy
- 08.25.2025 - Blog Post - OBIO | Strategic Recaps: The Power of Partnership and Future of AVIM Therapy
- 08.14.2025 - Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
- 08.14.2025 - Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
- 08.12.2025 - Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
- 08.12.2025 - Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
Recent Filings
- 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 08.08.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.08.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.08.2025 - 4 Statement of changes in beneficial ownership of securities